EUVIMEDEUVIMED entdecken
Crossref

Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere

Yun-Fei Dong, Yao-Sheng Li, Hui Liu, Lu Li, Juan-Juan Zheng, Ze-Feng Yang, Yuan-Kai Sun, Zhi-Wei Du, Dong-Hang Xu, Ni Li, Xin-Chi Jiang, Jian-Qing Gao

Journal of Controlled Release · 2024-07 · 371 · 484-497

DOI: 10.1016/j.jconrel.2024.06.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-07. Verfasst von Yun-Fei Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 31005…. Hauptthemen laut MEDLINE: Liposomes, Reperfusion Injury, Mesenchymal Stem Cells, Benzofurans. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation 2025 Major Project of Ningbo, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The precise and targeted delivery of therapeutic agents to the lesion sites remains a major challenge in treating brain diseases represented by ischemic stroke. Herein, we modified liposomes with mesenchymal stem cells (MSC) membrane to construct biomimetic liposomes, termed MSCsome. MSCsome (115.99 ± 4.03 nm) exhibited concentrated accumulation in the cerebral infarcted hemisphere of mice with cerebral ischemia-reperfusion injury, while showing uniform distribution in the two cerebral hemispheres of normal mice. Moreover, MSCsome exhibited high colocalization with damaged nerve cells in the infarcted hemisphere, highlighting its advantageous precise targeting capabilities over liposomes at both the tissue and cellular levels. Leveraging its superior targeting properties, MSCsome effectively delivered Dl-3-n-butylphthalide (NBP) to the injured hemisphere, making a single-dose (15 mg/kg) intravenous injection of NBP-encapsulated MSCsome facilitate the recovery of motor functions in model mice by improving the damaged microenvironment and suppressing neuroinflammation. This study underscores that the modification of the MSC membrane notably enhances the capacity of liposomes for precisely targeting the injured hemisphere, which is particularly crucial in treating cerebral ischemia-reperfusion injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesReperfusion InjuryMesenchymal Stem CellsBenzofuransDrug Delivery SystemsAnimalsMaleBrain IschemiaBiomimetic MaterialsMiceMice, Inbred C57BLMesenchymal Stem Cell Transplantation

Stichwörter der Autor:innen

Biomimetic strategyBrain targetingCerebral ischemia-reperfusion injuryFunctionalized liposomesMesenchymal stem cells

Substanzen

LiposomesBenzofurans3-n-butylphthalide

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, PR China.
  • Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, PR China.
  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, PR China; Department of Cardiothoracic Surgery, Ningbo Medical Cent…
  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, PR China; Institute of Innovative Medicine, College of Pharmaceutic…

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Innovation 2025 Major Project of Ningbo
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Dong, Y. F., Li, Y. S., Liu, H., Li, L., Zheng, J. J., Yang, Z. F., Sun, Y. K., Du, Z. W., Xu, D. H., Li, N., Jiang, X. C., & Gao, J. Q. (2024). Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere. Journal of Controlled Release, 371, 484-497. https://doi.org/10.1016/j.jconrel.2024.06.017

Vancouver

Dong YF, Li YS, Liu H, Li L, Zheng JJ, Yang ZF, et al. Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere. Journal of Controlled Release. 2024;371:484-497. doi:10.1016/j.jconrel.2024.06.017

BibTeX
@article{Dong2024,
  author = {Dong, Yun-Fei and Li, Yao-Sheng and Liu, Hui and Li, Lu and Zheng, Juan-Juan and Yang, Ze-Feng and Sun, Yuan-Kai and Du, Zhi-Wei and Xu, Dong-Hang and Li, Ni and Jiang, Xin-Chi and Gao, Jian-Qing},
  title = {Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {371},
  pages = {484--497},
  doi = {10.1016/j.jconrel.2024.06.017}
}
Kostenlos starten →